Cargando…
High prevalence of raised lipoprotein(a) in patients with refractory angina
Background: Angina that is refractory to conventional medical therapy and revascularisation, remains challenging to manage and poses significant burden to patients. Elevated lipoprotein(a) [Lp(a)] has emerged as an important independent cardiovascular risk factor and predictor of adverse outcomes in...
Autores principales: | Khan, Tina Z, Rhodes, Samantha, Pottle, Alison, Banya, Winston, Smith, Robert, Kabir, Tito, Ilsley, Charles, Pennell, Dudley J, Barbir, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bloomsbury Qatar Foundation Journals
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614330/ https://www.ncbi.nlm.nih.gov/pubmed/26779510 http://dx.doi.org/10.5339/gcsp.2015.28 |
Ejemplares similares
-
The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina
por: Khan, Tina Z, et al.
Publicado: (2014) -
Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
por: Khan, Tina, et al.
Publicado: (2015) -
Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
por: Khan, Tina Z., et al.
Publicado: (2021) -
Initial investigation of free-breathing 3D whole-heart stress myocardial perfusion MRI
por: Fair, Merlin J., et al.
Publicado: (2020) -
Investigation and Management of Stable Angina
por: Underwood, Richard, et al.
Publicado: (1993)